In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety ...
The following are key points to remember from a state-of-the-art review on treatment options for patients with secondary mitral regurgitation (SMR): ...
Galli M, Gragnano F, Berteotti M, et al., on behalf of the Working Group of Thrombosis of the Italian Society of Cardiology. Citation: Antithrombotic Therapy in High Bleeding Risk Part II: Non-Cardiac ...
In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...
Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...
A small proportion of patients with STEMI treated via primary PCI experienced late ventricular tachycardia (VT) or ventricular fibrillation (VF), occurring one or more days following the procedure, ...
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode two of four, Mr. Tom Draper talks with Mr. Adam DeJong and Dr. Malissa Wood about efforts required in the ...
The PARAMEDIC-3 trial showed that in patients with out-of-hospital cardiac arrest requiring drug administration, an intraosseous-first vascular access strategy did not increase 30-day survival ...
Participation in ACC’s Reduce the Risk: PCI Bleed Campaign was associated with a significant reduction of bleeding events following PCI, according to a study published in Circulation: Cardiovascular ...
The IVIO trial showed that in patients with nontraumatic out-of-hospital cardiac arrest requiring drug administration, an intraosseous-first vascular access strategy did not increase likelihood of ...
Anam Waheed, MD, FACC, spoke with Ron Blankstein, MD, FACC, about leadership, education and advocacy in the cardiovascular imaging field. Blankstein is a professor of Medicine and Radiology at Harvard ...
IVL TAVR was associated with a higher rate of the primary composite outcome driven by a higher rate of vascular complications, surgical vascular intervention, and major bleeding compared to non-IVL ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback